Skip to content

Effect of Gudaharitaki in the management of Pratisyaya wsr upper respiratory tract infection in Children.

Clinical study on Pratisyaya wsr to upper respiratory tract infection in children and its management with Gudaharitaki. - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066469
Enrollment
60
Registered
2024-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Dr Biswajeet Samal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pratisyaya with the positive sign and symptoms .

Exclusion criteria

Exclusion criteria: Pharyngitis Sinusitis Otitis media Raktaja and Dustapratisyaya Patient with TB Bronchial asthma Lower respiratory tract infection Swine flu COVID 19

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Gudaharitaki in management of Pratisyaya. Timepoint: 7days followed by 7days.

Secondary

MeasureTime frame
To compare the disease pratisyaya with Upper respiratory infection. To establish a safe remedy on the disease Pratisyaya & URTI.Timepoint: 14 days.

Countries

India

Contacts

Public ContactProf Dr Bijayalaxmi Pattanaik

Gopabandhu Ayurveda Mahavidyalaya Puri Odisha

laxmisagarblp@gmail.com8917495950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026